Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 33Tumor-Agnostic 25Thoracic 11Genitourinary 11Gastrointestinal 9Dermatologic 9Sarcoma 6Breast 5Endocrine 3Gynecologic 2Other hematologic neoplasm 1NET 1Lymphoid 1Head & Neck 1

Conditions

Hematologic Neoplasms 3Neoplasm Metastasis 1

Interventions

Leucovorin 4venetoclax 3Specimen Handling 3Fluorouracil 3Doxorubicin 3Cytarabine 3Cyclophosphamide 3Bevacizumab 3trametinib 2pembrolizumab 2dabrafenib 2Taxes 2Sorafenib 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Irinotecan 2Interleukin-2 2Gemcitabine 2Daunorubicin 2Carboplatin 2Bortezomib 2Biopsy 2Azacitidine 2Albumin-Bound Paclitaxel 2vactosertib 1temsirolimus 1ruxolitinib 1romidepsin 1regorafenib 1ponatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Radiosurgery × Other hematologic neoplasm × Clear all
NCT02710253 2026-05-15

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
230 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡